Perrigo Company PLC officially reaches the finish line on becoming a manufacturer entirely focused on consumer health product with the closing of its $1.55bn deal to divest its generic Rx product business to Altaris Capital Partners LLC.
It’s Official: Perrigo’s Entirely Consumer Health
"We are now a leading pure-play global consumer self-care company that has significant resources to invest,” says CEO Murray Kessler with Rx business sale closing.
More from Business
• By
Agreement with Seoul-based health and wellness player TopHealth will see the roll out of ProBiotix' cholesterol-lowering probiotics in South Korea.
• By
Italy's Alfasigma has expanded its operation in Germany with the creation of a new Consumer Healthcare unit. Led by Rüdiger Hoppe, the business is rolling out OTC medical devices and dietary supplements in the gastrointestinal category.
• By
Ibis Reproductive Health adds Desiree Williams to lead MORE Study; Radicle Science adds Rob Sinnott as senior strategic advisor; Leann Sims joins AbundaBox as COO; former Cannabis Beverage Association president moves to Vertosa; Vegamour expands executive staff with CMO; and Oura Ring firm appoints CMO.
• By
Arkopharma's parent company Dermapharm is undertaking a strategic shift at the French firm to help it better compete in the dietary supplements market after a tough year.
More from Wellness
• By
Arkopharma's parent company Dermapharm is undertaking a strategic shift at the French firm to help it better compete in the dietary supplements market after a tough year.
• By
Vitawell seeking to empower consumers left confused by the vast array of dietary supplements available to them in the UK.
• By
Tariffs on imports from China and look at eliminating self-affirmed GRAS pathway introduced under Trump while DoJ Consumer Protection Branch also continues supplement sector priorities enduring across administrations.